JP2015510491A5 - - Google Patents

Download PDF

Info

Publication number
JP2015510491A5
JP2015510491A5 JP2014537428A JP2014537428A JP2015510491A5 JP 2015510491 A5 JP2015510491 A5 JP 2015510491A5 JP 2014537428 A JP2014537428 A JP 2014537428A JP 2014537428 A JP2014537428 A JP 2014537428A JP 2015510491 A5 JP2015510491 A5 JP 2015510491A5
Authority
JP
Japan
Prior art keywords
composition
formulation
pharmaceutical composition
sodium
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014537428A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015510491A (ja
JP6240610B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2012/001315 external-priority patent/WO2013059881A1/en
Publication of JP2015510491A publication Critical patent/JP2015510491A/ja
Publication of JP2015510491A5 publication Critical patent/JP2015510491A5/ja
Application granted granted Critical
Publication of JP6240610B2 publication Critical patent/JP6240610B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014537428A 2011-10-27 2012-10-27 電解質下剤 Expired - Fee Related JP6240610B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161552431P 2011-10-27 2011-10-27
US61/552,431 2011-10-27
US201261717599P 2012-10-23 2012-10-23
US61/717,599 2012-10-23
PCT/AU2012/001315 WO2013059881A1 (en) 2011-10-27 2012-10-27 Electrolyte purgatives

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017153176A Division JP2018008997A (ja) 2011-10-27 2017-08-08 電解質下剤

Publications (3)

Publication Number Publication Date
JP2015510491A JP2015510491A (ja) 2015-04-09
JP2015510491A5 true JP2015510491A5 (enExample) 2017-03-09
JP6240610B2 JP6240610B2 (ja) 2017-11-29

Family

ID=48166953

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014537428A Expired - Fee Related JP6240610B2 (ja) 2011-10-27 2012-10-27 電解質下剤
JP2017153176A Pending JP2018008997A (ja) 2011-10-27 2017-08-08 電解質下剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017153176A Pending JP2018008997A (ja) 2011-10-27 2017-08-08 電解質下剤

Country Status (14)

Country Link
US (1) US20150056140A1 (enExample)
EP (1) EP2782581A4 (enExample)
JP (2) JP6240610B2 (enExample)
KR (1) KR20140090217A (enExample)
CN (1) CN104010642B (enExample)
AU (2) AU2012327212B2 (enExample)
BR (1) BR112014009946A2 (enExample)
CA (1) CA2853520C (enExample)
IL (1) IL232218B (enExample)
IN (1) IN2014DN03373A (enExample)
MX (1) MX352891B (enExample)
PH (1) PH12014500927B1 (enExample)
RU (1) RU2640920C2 (enExample)
WO (1) WO2013059881A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG191145A1 (en) 2010-12-13 2013-07-31 Borody Thomas J Gastric and colonic formulations and methods for making and using them
TWI535461B (zh) 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
WO2014016671A2 (en) 2012-07-27 2014-01-30 Redhill Biopharma Ltd. Formulations and methods of manufacturing formulations for use in colonic evacuation
KR20170098980A (ko) 2012-09-11 2017-08-30 노어긴 비.브이. Peg 및 아스코르베이트를 포함하는 조성물
CA2903283C (en) 2013-03-15 2023-09-05 Braintree Laboratories, Inc. Dual use oral pharmaceutical composition tablets of sulfate salts and methods of use thereof
CN103585173B (zh) * 2013-10-28 2016-06-29 王显著 含硫酸钠和匹可硫酸的药物组合物
EP3191105A4 (en) * 2014-09-12 2018-05-02 Braintree Laboratories, Inc. Sulfate salt solution laxative compositions and methods of use thereof
FR3049464B1 (fr) * 2016-03-29 2021-08-06 Marc Girard Preparations coliques
US10143656B1 (en) 2017-08-04 2018-12-04 Braintree Laboratories, Inc. Solid oral sulfate salt formulations for cleaning a colon and methods of using same
KR102127003B1 (ko) * 2017-10-12 2020-06-25 주식회사 한국팜비오 황산염을 포함하는 대장 하제 조성물
CN108244627A (zh) * 2018-01-16 2018-07-06 广西天昌投资有限公司 一种具有润肠功能的香蕉口服液及其制备方法
KR102111094B1 (ko) * 2018-06-18 2020-05-14 주식회사 한국팜비오 무수황산나트륨, 황산칼륨, 무수황산마그네슘 및 시메티콘을 포함하는 장관하제 경구투여용 고형제제 조성물
WO2020006389A1 (en) * 2018-06-29 2020-01-02 Viktor Veniaminovich Tets Compositions for modulating gut microbiota
RU2699222C1 (ru) * 2019-04-29 2019-09-04 Алексей Владимирович Воронов Солевой электролитный раствор для проведения энтеральных инфузий
RU2709495C1 (ru) * 2019-08-01 2019-12-18 Общество с ограниченной ответственностью "Гелеспон" Способ очищения кишечника и набор для его осуществления
KR20220122613A (ko) * 2019-12-23 2022-09-02 주식회사 비보존 대장 하제 조성물
KR20220033810A (ko) * 2020-09-10 2022-03-17 강윤식 장 정결용 보조 음료
US12239659B2 (en) 2023-06-15 2025-03-04 Braintree Laboratories, Inc. Methods of administering safe colon cleansing compositions
WO2025259039A1 (ko) * 2024-06-13 2025-12-18 주식회사태준제약 장정결을 위한 고형제제
GR20240100543A (el) * 2024-08-01 2026-03-10 Αθανασιος Μιγδανης Ηλεκτρολυτικο διαλυμα (για εντερικη χρηση) που προοριζεται για ασθενεις που φερουν προφυλακτικη ειλεοστομια μεταγχειρητικα

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6162464A (en) * 1997-03-31 2000-12-19 Inkine Pharmaceutical, Inc. Non-aqueous colonic purgative formulations
JP2000060487A (ja) * 1998-08-27 2000-02-29 Kao Corp 便秘改善剤
EE04580B1 (et) * 2001-06-29 2006-02-15 Tartu �likool Mikroorganismi tüvi Lactobacillus fermentum ME-3 kui antimikroobne ja antioksüdantne probiootikum
US7101573B2 (en) * 2001-09-28 2006-09-05 Mcneil-Pcc, Inc. Simethicone solid oral dosage form
AUPS088702A0 (en) * 2002-03-04 2002-03-28 Borody, Thomas Julius Electrolyte purgative
JP4458761B2 (ja) * 2003-03-27 2010-04-28 ロート製薬株式会社 瀉下用製剤
US7687075B2 (en) * 2003-11-19 2010-03-30 Salix Pharmaceuticals, Ltd. Colonic purgative composition with soluble binding agent
GB0409104D0 (en) * 2004-04-23 2004-05-26 Norgine Europe Bv Compressed pharmaceutical compositions
WO2008134071A1 (en) * 2007-04-26 2008-11-06 Theraquest Biosciences, Inc. Multimodal abuse resistant extended release formulations
WO2007057924A1 (en) * 2005-11-21 2007-05-24 Panacea Biotec Ltd Laxative composition on the basis of triphala
WO2008021394A2 (en) * 2006-08-15 2008-02-21 Theraquest Biosciences, Llc Pharmaceutical formulations of cannabinoids and method of use
JP2008115085A (ja) * 2006-11-01 2008-05-22 Tendou Seiyaku Kk 緩下剤
US20090155363A1 (en) * 2007-12-14 2009-06-18 Todd Maibach Methods for oral administration of active drugs
US20090258090A1 (en) * 2008-04-11 2009-10-15 Braintree Laboratories, Inc. Colon cleansing solution
WO2011047178A1 (en) * 2009-10-14 2011-04-21 Gi Innovation, Pllc Colon cleansing of residual stool and secretions during colonoscopy
JP2011135936A (ja) * 2009-12-25 2011-07-14 Toshiba Corp 画像処理装置、医用画像診断装置および画像処理プログラム
SG191145A1 (en) * 2010-12-13 2013-07-31 Borody Thomas J Gastric and colonic formulations and methods for making and using them
RU2651751C2 (ru) * 2011-01-28 2018-04-23 Уильям А. ШЕЙВЕР Способ, композиция и набор для чистки кишечника

Similar Documents

Publication Publication Date Title
JP2018008997A5 (enExample)
RU2014121255A (ru) Электролитные слабительные средства
HRP20190146T4 (hr) Uporaba cirkonijevog silikata za liječenje hiperkalemije
RU2013138672A (ru) Способ, композиция и набор для чистки кишечника
JP2012031131A5 (enExample)
JP2014502598A5 (enExample)
NL2004260C2 (en) Disinfectant composition and its use in dental treatment.
JP2013523677A5 (enExample)
JP2010526101A5 (enExample)
JP2012519201A5 (enExample)
JP2015517572A5 (enExample)
JP2015520151A5 (enExample)
JP2014515408A5 (enExample)
JP2014506914A5 (enExample)
HRP20151327T1 (hr) Farmaceutska kombinacija za lijeäśenje boli
HRP20241087T1 (hr) Konjugirani protusmisleni spojevi za upotrebu u terapiji
JP2012236834A5 (enExample)
JP2010528045A5 (enExample)
JP2014507462A5 (enExample)
CN101636156A (zh) 没食子酸烷基酯的药物组合物
RU2018111690A (ru) Пероральная лекарственная форма будесонида
HRP20140215T1 (hr) Kombinacija koja sadrži paklitaksel za lijeäśenje raka jajnika
RU2019109695A (ru) Лекарственная форма для пролонгированного ослабления симптомов
JP2013544795A5 (enExample)
JP2014530204A5 (enExample)